文献速递肝病消化道肿瘤与早癌

肿瘤微环境塑造肝细胞癌患者的固有淋巴细胞

The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.
PubMed 文献 · Gut · 2021-08-02

该研究对48例肝细胞癌患者的非肿瘤肝组织、边缘区和肿瘤核心进行批量RNA测序、流式细胞术和单细胞RNA测序,发现肿瘤细胞因子梯度引导固有淋巴细胞可塑性变化,高ILC2/ILC1比值且肿瘤表达IL-33者生存更好。

要点

  • 肿瘤细胞因子梯度驱动ILC可塑性,非肿瘤组织NK样细胞向肿瘤ILC1和NK样ILC3转变。
  • 肿瘤ILC2升高由IL-33促进,高ILC2/ILC1比值与更好生存相关。
  • ILC组成变化为肝脏特异性,外周血单核细胞中未观察到。

核心结论

  • 肿瘤细胞因子微环境控制ILC组成并影响肝细胞癌结局。
  • 细胞因子变化通过诱导可塑性改变肿瘤内ILC组成和功能。

研究设计与样本

  • 对48例肝细胞癌患者的非肿瘤肝组织、边缘区和肿瘤核心进行批量RNA测序。
  • 对富集ILC进行流式细胞术和单细胞RNA测序,并用AbSeq同时检测单细胞蛋白和RNA表达。
  • 体外培养ILC验证计算机分析结果,并分析大型HCC队列RNA测序数据做分层和生存分析。

主要发现

  • 肿瘤、非肿瘤和边缘区RNA测序识别出肿瘤依赖的梯度,与不良生存和ILC可塑性控制相关。
  • 非肿瘤组织中NK样细胞在向肿瘤ILC1和NK样ILC3转变过程中失去细胞毒表型。
  • 肿瘤ILC组成由细胞因子梯度介导,引导ILC可塑性向活化肿瘤ILC2转变。
  • 该变化为肝脏特异性,外周血单核细胞ILC中未见。
  • 高ILC2/ILC1比值者肿瘤表达IL-33促进ILC2生成,与更好生存相关。

临床怎么用

  • 关注肿瘤细胞因子梯度对ILC组成的塑造,高ILC2/ILC1比值和IL-33表达可能提示更好生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hepatocellular carcinoma (HCC) represents a typical inflammation-associated cancer. Tissue resident innate lymphoid cells (ILCs) have been suggested to control tumour surveillance. Here, we studied how the local cytokine milieu controls ILCs in HCC. DESIGN: We performed bulk RNA sequencing of HCC tissue as well as flow cytometry and single-cell RNA sequencing of enriched ILCs from non-tumour liver, margin and tumour core derived from 48 patients with HCC. Simultaneous measurement of protein and RNA expression at the single-cell level (AbSeq) identified precise signatures of ILC subgroups. In vitro culturing of ILCs was used to validate findings from in silico analysis. Analysis of RNA-sequencing data from large HCC cohorts allowed stratification and survival analysis based on transcriptomic signatures. RESULTS: RNA sequencing of tumour, non-tumour and margin identified tumour-dependent gradients, which were associated with poor survival and control of ILC plasticity. Single-cell RNA sequencing and flow cytometry of ILCs from HCC livers identified natural killer (NK)-like cells in the non-tumour tissue, losing their cytotoxic profile as they transitioned into tumour ILC1 and NK-like-ILC3 cells. Tumour ILC composition was mediated by cytokine gradients that directed ILC plasticity towards activated tumour ILC2s. This was liver-specific and not seen in ILCs from peripheral blood mononuclear cells. Patients with high ILC2/ILC1 ratio expressed interleukin-33 in the tumour that promoted ILC2 generation, which was associated with better survival. CONCLUSION: Our results suggest that the tumour cytokine milieu controls ILC composition and HCC outcome. Specific changes of cytokines modify ILC composition in the tumour by inducing plasticity and alter ILC function.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Heinrich B, Gertz EM, Schäffer AA, et al. The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma. Gut. 2021. PMID: 34340996. doi:10.1136/gutjnl-2021-325288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。